MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge

Am J Physiol Cell Physiol. 2007 Aug;293(2):C632-40. doi: 10.1152/ajpcell.00137.2006. Epub 2007 Apr 18.

Abstract

L-Arginine (L-arg) is metabolized to nitric oxide (NO) by inducible NO synthase (iNOS) or to urea and L-ornithine (L-orn) by arginase. NO is involved in the inflammatory response, whereas arginase is the first step in polyamine and proline synthesis necessary for tissue repair and wound healing. Mitogen-activated protein kinases (MAPK) mediate LPS-induced iNOS expression, and MAPK phosphatase-1 (MKP-1) plays a crucial role in limiting MAPK signaling in macrophages. We hypothesized that MKP-1, by attenuating iNOS expression, acts as a switch changing L-arg metabolism from NO production to L-orn production after endotoxin administration. To test this hypothesis, we performed studies in RAW264.7 macrophages stably transfected with an MKP-1 expression vector in thioglyollate-elicited peritoneal macrophages harvested from wild-type and Mkp-1(-/-) mice, as well as in vivo in wild-type and Mkp-1(-/-) mice. We found that overexpression of MKP-1 resulted in lower iNOS expression and NO production but greater urea production in response to LPS. Although deficiency of MKP-1 resulted in greater iNOS expression and NO production and lower urea production in response to LPS, neither the overexpression nor the deficiency of MKP-1 had any substantial effect on the expression of the arginases.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Arginase / genetics
  • Arginase / metabolism*
  • Arginine / metabolism*
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism*
  • Cell Line
  • Dual Specificity Phosphatase 1
  • Gene Expression Regulation, Enzymologic
  • Immediate-Early Proteins / deficiency
  • Immediate-Early Proteins / genetics
  • Immediate-Early Proteins / metabolism*
  • Inflammation / enzymology
  • Inflammation / genetics
  • Inflammation / metabolism*
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lipopolysaccharides / pharmacology*
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / enzymology
  • Macrophages, Peritoneal / metabolism
  • Mice
  • Mice, Knockout
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism*
  • Ornithine / metabolism
  • Phosphoprotein Phosphatases / deficiency
  • Phosphoprotein Phosphatases / genetics
  • Phosphoprotein Phosphatases / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Phosphatase 1
  • Protein Tyrosine Phosphatases / deficiency
  • Protein Tyrosine Phosphatases / genetics
  • Protein Tyrosine Phosphatases / metabolism*
  • RNA, Messenger / metabolism
  • Time Factors
  • Transfection
  • Urea / metabolism
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Cell Cycle Proteins
  • Immediate-Early Proteins
  • Lipopolysaccharides
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • lipopolysaccharide, E coli O55-B5
  • Nitric Oxide
  • Urea
  • Arginine
  • Ornithine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Phosphoprotein Phosphatases
  • Protein Phosphatase 1
  • Dual Specificity Phosphatase 1
  • Dusp1 protein, mouse
  • Protein Tyrosine Phosphatases
  • Arg2 protein, mouse
  • Arginase